DEFINITIVE PROXY STATEMENT

Company

ORAMED PHARMACEUTICALS INC.

Filed

August 1, 2017

Period of Report

August 30, 2017

Accession Number

0001213900-17-008089

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →